|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| C07D 401/14 | |||
| C07D 413/14 | |||
| A61K 31/454 | |||
| A61K 31/4545 | |||
| A61K 31/506 | |||
| A61K 31/5377 | |||
| A61P 3/00 |
| (11) | Number of the document | 2568812 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11781053.1 |
| Date of filing the European patent application | 2011-05-06 | |
| (97) | Date of publication of the European application | 2013-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/035501 |
| Date | 2011-05-06 |
| (87) | Number | WO 2011/143057 |
| Date | 2011-11-17 |
| (30) | Number | Date | Country code |
| 333451 P | 2010-05-11 | US |
| (72) |
HALE, Jeffrey, J., US
JIANG, Jinlong, US
SHEN, Dong-Ming, US
SHI, Zhi-Cai, US
SHU, Min, US
WU, Zhicai, US
YANG, Cangming, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS |
| NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS |